SEC Filing Summary: National Health Investors Inc (NHI)
Business Context and Reporting Period
This Form 8-K was filed by National Health Investors Inc on February 26, 2026. The filing serves as a Regulation FD disclosure to furnish Supplemental Information for the quarter ended December 31, 2025. The company is incorporated in Maryland and trades on the New York Stock Exchange under the symbol NHI.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced Supplemental Information (Exhibit 99.1) and the company's website, which are not included in the provided text.
Material Changes
The filing does not detail specific material changes versus the prior comparable period. It solely references the availability of supplemental data for the fourth quarter of 2025.
Guidance, Outlook, and Risks
The text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies and unusual items. The document functions as a notice of the availability of the supplemental report.
Investor Verification Checklist
- Verify the specific financial results for the quarter ended December 31, 2025, by reviewing Exhibit 99.1 or the company website (www.nhireit.com).
- Confirm the details of the Supplemental Information to assess performance against prior periods.
- Review the full text of the supplemental report for any management commentary or updated outlook not present in this 8-K summary.